Philipp Kwame Abayie Agyeman

Dr. Philipp Kwame Abayie Agyeman

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
EGEric Giannoni
Eric Giannoni
PAPhilipp Kwame Abayie Agyeman
Philipp Kwame Abayie Agyeman
MSMartin Stocker
Martin Stocker
KPKlara M. Posfay-Barbe
Klara M. Posfay-Barbe
UHUlrich Heininger
Ulrich Heininger
LSLuregn J. Schlapbach
Luregn J. Schlapbach

1 August 2004 in Infection
Verified
Journal Article
Closed access
PDF file
PAPhilipp Kwame Abayie Agyeman
Philipp Kwame Abayie Agyeman
ADA. Duppenthaler
A. Duppenthaler
UHU. Heininger
U. Heininger
CAChristoph Aebi
Christoph Aebi

1 October 2017 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
PAPhilipp Kwame Abayie Agyeman
Philipp Kwame Abayie Agyeman
LSLuregn J Schlapbach
Luregn J Schlapbach
EGEric Giannoni
Eric Giannoni
MSMartin Stocker
Martin Stocker
KPKlara M Posfay-Barbe
Klara M Posfay-Barbe
CBChristoph Berger
Christoph Berger

27 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMartin Stocker
Martin Stocker
CKClaus Klingenberg
Claus Klingenberg
LNLars Navér
Lars Navér
VNViveka Nordberg
Viveka Nordberg
ABAlberto Berardi
Alberto Berardi
EGEric Giannoni
Eric Giannoni
Antibiotic exposure at the beginning of life can lead to increased antimicrobial resistance and perturbations of the developing microbiome. Early-life microbiome disruption increases the risks of developing chronic diseases later in life. Fear of missing evolving neonatal sepsis is the key driver for antibiotic overtreatment early in life. Bias (a systemic deviation towards overtreatment) and noise (a random scatter) affect the decision-making process. In this perspective, we advocate for a factual approach quantifying the burden of treatment in relation to the burden of disease balancing antimicrobial stewardship and effective sepsis management.

20 February 2012 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MHMarkus Hilty
Markus Hilty
WQWeihong Qi
Weihong Qi
SBSilvio D. Brugger
Silvio D. Brugger
LFLaurence Frei
Laurence Frei
PAPhilipp Kwame Abayie Agyeman
Philipp Kwame Abayie Agyeman
KMKathrin Mühlemann
Kathrin Mühlemann
Background. Interspecies interactions of the nasopharyngeal microbiota are likely to be involved in the pathogenesis of acute otitis media (AOM). Capturing the breadth of microbial interactions requires a detailed description of the microbiota during health and AOM. Methods. The nasopharyngeal microbiota of 163 infants with (n = 153) or without (n = 10) AOM was characterized using nasopharyngeal swabs and multiplexed pyrosequencing of 16S rRNA. Nasopharyngeal swab specimens were collected during 4 winter seasons from 2004 through 2010 for infants with AOM and during 2010 for controls. Results. Fifty-eight bacterial families were identified, of which Moraxellaceae, Streptococcaceae, and Pasteurellaceae were the most frequent. Commensal families were less prevalent in infants with AOM than in controls. In infants with AOM, prior exposure to antimicrobials and administration of the heptavalent conjugated pneumococcal polysaccharide vaccine (PCV7) were also associated with reduced prevalence of distinct commensal families (Streptococcaceae and Corynebacteriaceae). In addition, antimicrobial exposure increased the prevalence of Enterobacteriaceae and the abundance of Pasteurellaceae. Other factors, such as age, sex, day care, and a history of recurrent AOM, did not influence the microbiota. Conclusions. Infants’ nasopharyngeal microbiota undergoes significant changes during AOM and after exposure to antimicrobials and PCV7, which is mainly attributable to reduced prevalence of commensal bacterial families.

3 July 2020 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
MBMichael Buettcher
Michael Buettcher
JTJohannes Trueck
Johannes Trueck
ANAnita Niederer-Loher
Anita Niederer-Loher
UHUlrich Heininger
Ulrich Heininger
PAPhilipp Kwame Abayie Agyeman
Philipp Kwame Abayie Agyeman
TNThomas J. Neuhaus
Thomas J. Neuhaus
The kidneys and the urinary tract are a common source of infection in children of all ages, especially infants and young children. The main risk factors for sequelae after urinary tract infections (UTI) are congenital anomalies of the kidney and urinary tract (CAKUT) and bladder-bowel dysfunction. UTI should be considered in every child with fever without a source. The differentiation between upper and lower UTI is crucial for appropriate management. Method of urine collection should be based on age and risk factors. The diagnosis of UTI requires urine analysis and significant growth of a pathogen in culture. Treatment of UTI should be based on practical considerations regarding age and presentation with adjustment of the initial antimicrobial treatment according to antimicrobial sensitivity testing. All children, regardless of age, should have an ultrasound of the urinary tract performed after pyelonephritis. In general, antibiotic prophylaxis is not recommended.Conclusion: Based on recent data and in line with international guidelines, multidisciplinary Swiss consensus recommendations were developed by members of Swiss pediatric infectious diseases, nephrology, and urology societies giving the clinician clear recommendations in regard to diagnosis, type and duration of therapy, antimicrobial treatment options, indication for imaging, and antibiotic prophylaxis. What is Known:•Urinary tract infections (UTI) are a common and important clinical problem in childhood. Although children with pyelonephritis tend to present with fever, it can be difficult on clinical grounds to distinguish cystitis from pyelonephritis, particularly in young children less than 2 years of age.•Method of urine collection is based on age and risk factors. The diagnosis of UTI requires urine analysis and significant growth of a pathogen in culture. What is New:•Vesicoureteric reflux (VUR) remains a risk factor for UTI butper seis neither necessary nor sufficient for the development of renal scars. Congenital anomalies of the kidney and urinary tract (CAKUT) and bladder-bowel dysfunction play a more important role as causes of long-term sequelae. In general, antibiotic prophylaxis is not recommended.•A switch to oral antibiotics should be considered already in young infants. Indications for invasive imaging are more restrictive and reserved for patients with abnormal renal ultrasound, complicated UTI, and infections with pathogens other than E. coli.